動物用疼痛管理市場：製品（薬物（NSAIDs、Opioids）、投与経路（経口、非経口）、デバイス（レーザー））、用途（関節痛、癌）、動物（コンパニオン、家畜）、エンドユーザー（病院、薬局）別 - 2027年までの世界市場予測

Veterinary Pain Management Market by Product (Drug (NSAIDs, Opioids), Route of Administration (Oral, Parenteral), Device (Laser)), Application (Joint Pain, Cancer), Animal (Companion and Livestock), End User (Hospital, Pharmacy) - Global Forecast to 2027

動物用疼痛管理市場は、2022年の18億米ドルから2027年には25億米ドルに達すると予測され、予測期間中のCAGRは6.7%となります。この市場は、製品、アプリケーション、動物、エンドユーザー、地域によって細分化さ... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年9月22日	US$4,950 シングルユーザライセンスライセンス・価格情報・注文方法はこちら	287	355	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

動物用疼痛管理市場は、2022年の18億米ドルから2027年には25億米ドルに達すると予測され、予測期間中のCAGRは6.7%となります。この市場は、製品、アプリケーション、動物、エンドユーザー、地域によって細分化されています。

"2021年の薬剤タイプ別動物用疼痛管理市場においてオピオイドセグメントが2位のシェアを占める"
獣医用疼痛管理薬市場は、薬剤タイプ別にNSAIDs、オピオイド、局所麻酔薬、α2アゴニスト、疾患修飾性変形性関節症治療薬、その他の薬剤に区分される。2021年、オピオイドセグメントは動物用疼痛管理薬市場で2番目に大きなシェアを占めています。
"2021年、レーザー治療器セグメントが動物用疼痛管理市場の機器タイプ別で最大シェアを占める"
獣医用疼痛管理装置の種類に基づき、市場はレーザー療法装置と電磁場療法装置に区分される。2021年にはレーザー治療機器セグメントが最大のシェアを占めています。レーザー療法は、急性および慢性の幅広い疼痛状態の治療に有効であり、痛みの原因を特定して治療するため、痛みを伴う侵襲的な手術や鎮痛剤のさらなる使用の必要性が排除されます。このような利点が、動物用疼痛管理機器市場におけるレーザー治療機器の成長を促進すると期待されています。
"2021年コンパニオンアニマル獣医疼痛管理市場の最大シェアを占めるのは犬"
動物の種類に基づき、獣医学的疼痛管理市場はコンパニオンアニマルと畜産動物に区分される。コンパニオンアニマルセグメントは、2021年の獣医学的疼痛管理市場で最大のシェアを占めています。このセグメントの大きなシェアは、コンパニオンアニマル所有の増加、ペット所有者の動物の健康に対する意識の高まり、ペット医療費の上昇に起因すると考えられる

"中国は2021年にAPACの獣医学的疼痛管理市場の最高成長率を登録すると予測される"
中国市場は、予測期間中に最も高いCAGRで成長すると推定されます。獣医手術の増加、ペット保険の増加、動物由来因子の需要増加、動物病院や診療所の増加などの要因が、予測期間中の獣医学的疼痛管理市場における中国市場の成長に寄与しています。

本レポートで参照した獣医学的疼痛管理市場の主要参加者（供給側）の内訳は以下の通りです。
- 企業タイプ別企業タイプ別：Tier 1-45%、Tier 2-34%、Tier 3-21
- 役職別Cレベル-26%、Directorレベル-30%、その他-44
- 地域別北米-35％、欧州-32％、アジア太平洋-25％、中南米-6％、中東・アフリカ-2
動物用疼痛管理市場の有力企業は、Boehringer Ingelheim International GmbH（ドイツ）、Zoetis Inc（米国）、Elanco Animal Health Incorporated（米国）、Merck & Co, Inc（米国）、Dechra Pharmaceuticals（英国）、Vetoquinol（フランス）、Sequent Scientific Limited（インド）、Norbrook Laboratories Limited（アイルランド）、Ceva Santé Animale（フランス）、Chanelle Pharma（アイルランド）および K-Laser USA（米国）です。新製品の発売と買収は、これらの支払者が動物用疼痛管理市場での地位を維持するために採用した主要な戦略でした。
調査対象範囲
本市場調査は、様々なセグメントにわたる獣医学的疼痛管理市場を対象としています。製品、アプリケーションの種類、動物の種類、エンドユーザー、地域など、さまざまなセグメントにおける市場規模および市場の成長性を推定することを目的としています。また、市場の主要企業の詳細な競合分析、企業プロファイル、製品や事業の提供に関する主な見解、最近の開発、主要な市場戦略も掲載しています。
レポート購入の主なメリット
本レポートは、この市場における市場リーダー/新規参入者を支援し、獣医用疼痛管理市場およびそのセグメントの最も近い近似値に関する情報を提供するものです。本レポートは、利害関係者が競争環境を理解し、自社のビジネスをより良く位置づけるための洞察を得て、適切な市場参入戦略を計画するのに役立ちます。また、市場の脈動を理解し、主要な市場促進要因、阻害要因、機会、課題に関する情報を得る上で、ステークホルダーの助けとなります。

ページTOPに戻る

1 INTRODUCTION 40
1.1 STUDY OBJECTIVES 40
1.2 MARKET DEFINITION 40
1.2.1 INCLUSIONS & EXCLUSIONS 41
1.3 MARKET SCOPE 42
1.3.1 MARKETS COVERED 42
FIGURE 1 VETERINARY PAIN MANAGEMENT MARKET SEGMENTATION 42
1.3.2 REGIONAL MARKETS COVERED 43
1.3.3 YEARS CONSIDERED 43
1.4 CURRENCY CONSIDERED 44
TABLE 1 STANDARD CURRENCY CONVERSION RATES 44
1.5 LIMITATIONS 44
1.6 STAKEHOLDERS 44
1.7 SUMMARY OF CHANGES 45
2 RESEARCH METHODOLOGY 46
2.1 RESEARCH APPROACH 46
2.2 RESEARCH METHODOLOGY DESIGN 46
FIGURE 2 VETERINARY PAIN MANAGEMENT MARKET: RESEARCH DESIGN 46
2.2.1 SECONDARY RESEARCH 47
2.2.1.1 Key data from secondary sources 48
2.2.2 PRIMARY DATA 49
FIGURE 3 PRIMARY SOURCES 49
2.2.2.1 Key data from primary sources 50
2.2.2.2 Insights from primary experts 51
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 51
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 52
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 52
2.3 MARKET SIZE ESTIMATION 53
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 54
FIGURE 8 SUPPLY-SIDE MARKET SIZE ESTIMATION: VETERINARY PAIN MANAGEMENT MARKET (2021) 54
FIGURE 9 TOP-DOWN APPROACH 55
FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 57

2.4 MARKET BREAKDOWN & DATA TRIANGULATION 58
FIGURE 12 DATA TRIANGULATION METHODOLOGY 58
2.5 MARKET SHARE ESTIMATION 59
2.6 ASSUMPTIONS 59
2.7 RISK ASSESSMENT 59
3 EXECUTIVE SUMMARY 60
FIGURE 13 VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION) 60
FIGURE 14 VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 61
FIGURE 15 VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2022 VS. 2027 (USD MILLION) 61
FIGURE 16 VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 62
FIGURE 17 VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 63
FIGURE 18 VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2022 VS. 2027 (USD MILLION) 63
FIGURE 19 VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 64
FIGURE 20 GEOGRAPHICAL SNAPSHOT OF VETERINARY PAIN MANAGEMENT MARKET 65
4 PREMIUM INSIGHTS 66
4.1 VETERINARY PAIN MANAGEMENT MARKET OVERVIEW 66
FIGURE 21 GROWTH IN COMPANION ANIMAL ADOPTION AND INCREASING PREVALENCE OF ANIMAL DISEASES TO DRIVE MARKET GROWTH 66
4.2 VETERINARY PAIN MANAGEMENT MARKET: REGIONAL MIX 67
FIGURE 22 ASIA PACIFIC MARKET TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 67
4.3 ASIA PACIFIC: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT AND COUNTRY (2021) 68
FIGURE 23 VETERINARY PAIN MANAGEMENT DRUGS SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2021 68
4.4 VETERINARY PAIN MANAGEMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 69
FIGURE 24 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 69
4.5 VETERINARY PAIN MANAGEMENT MARKET: DEVELOPED VS. DEVELOPING MARKETS 70
FIGURE 25 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 70
5 MARKET OVERVIEW 71
5.1 INTRODUCTION 71
5.2 MARKET DYNAMICS 71
FIGURE 26 VETERINARY PAIN MANAGEMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 71
5.2.1 MARKET DRIVERS 72
5.2.1.1 Growth in companion animal population 72
TABLE 2 PET POPULATION, BY ANIMAL, 2014–2020 (MILLION) 73
5.2.1.2 Increasing consumption of meat & milk 73
TABLE 3 PAST AND PROJECTED TRENDS IN CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING COUNTRIES 73
TABLE 4 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 74
5.2.1.3 Growing prevalence of diseases 74
5.2.1.4 Increasing number of veterinary practitioners in developed economies 75
TABLE 5 NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012–2020 75
5.2.2 MARKET RESTRAINTS 75
5.2.2.1 Rising pet care costs 75
FIGURE 27 US: BASIC ANNUAL EXPENSES FOR DOGS AND CATS, 2021 76
5.2.3 MARKET OPPORTUNITIES 76
5.2.3.1 Increasing popularity of non-conventional and non-pharmaceutical treatment techniques 76
5.2.3.2 Untapped emerging markets 77
5.2.4 MARKET CHALLENGES 77
5.2.4.1 Stringent regulatory process 77
5.3 TECHNOLOGY ANALYSIS 77
5.3.1 KEY TECHNOLOGIES 77
5.3.1.1 Development of low-level light therapy/laser therapy/photobiomodulation 77
TABLE 6 SOME COMMERCIALLY AVAILABLE LASER THERAPY INSTRUMENTS 78
5.4 ECOSYSTEM ANALYSIS 78
TABLE 7 VETERINARY PAIN MANAGEMENT MARKET: ECOSYSTEM MAPPING 78
FIGURE 28 VETERINARY PAIN MANAGEMENT MARKET: ECOSYSTEM MARKET MAP 79
5.5 AVERAGE SELLING PRICE TRENDS 80
5.5.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY APPLICATION 80
TABLE 8 PRICING ANALYSIS OF PAIN MANAGEMENT PRODUCTS OFFERED BY LEADING PLAYERS (USD) 80
5.6 PATENT ANALYSIS 80
5.6.1 PATENT PUBLICATION TRENDS FOR VETERINARY PAIN MANAGEMENT PRODUCTS 80
FIGURE 29 PATENT PUBLICATION TRENDS (JANUARY 2012–AUGUST 2022) 81
5.6.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 81
FIGURE 30 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY PAIN MANAGEMENT (JANUARY 2012–JULY 2022) 82
FIGURE 31 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY PAIN MANAGEMENT PATENTS (JANUARY 2012–JULY 2022) 83
5.7 VALUE CHAIN ANALYSIS 83
FIGURE 32 VETERINARY PAIN MANAGEMENT MARKET: VALUE CHAIN ANALYSIS 84

5.8 SUPPLY CHAIN ANALYSIS 84
FIGURE 33 VETERINARY PAIN MANAGEMENT MARKET: SUPPLY CHAIN ANALYSIS 85
5.9 PORTER’S FIVE FORCES ANALYSIS 86
FIGURE 34 VETERINARY PAIN MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 86
TABLE 9 VETERINARY PAIN MANAGEMENT MARKET: PORTER’S FIVE FORCES ANALYSIS 86
5.9.1 THREAT FROM NEW ENTRANTS 87
5.9.2 THREAT FROM SUBSTITUTES 87
5.9.3 BARGAINING POWER OF SUPPLIERS 88
5.9.4 BARGAINING POWER OF BUYERS 88
5.9.5 INTENSITY OF COMPETITIVE RIVALRY 88
5.10 KEY CONFERENCES & EVENTS DURING 2022–2023 89
TABLE 10 VETERINARY PAIN MANAGEMENT MARKET: DETAILED LIST OF CONFERENCES & EVENTS 89
5.11 KEY STAKEHOLDERS & BUYING CRITERIA 90
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 90
FIGURE 35 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS 90
TABLE 11 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS 90
5.11.2 BUYING CRITERIA 91
FIGURE 36 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 91
TABLE 12 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 91
5.12 TRENDS AND DISRUPTIONS AFFECTING CUSTOMERS’ BUSINESSES 92
FIGURE 37 VETERINARY PAIN MANAGEMENT MARKET: TRENDS AND DISRUPTIONS AFFECTING CUSTOMERS’ BUSINESSES 92
5.13 TRADE ANALYSIS 92
5.14 INDUSTRY TRENDS 92
5.14.1 ADOPTION OF REGENERATIVE MEDICINE 92
5.15 REGULATORY ANALYSIS 93
5.15.1 REGULATORY LANDSCAPE 93
FIGURE 38 DEVELOPMENT AND APPROVAL PROCESS FOR ANIMAL PHARMACEUTICAL PRODUCTS 95
5.15.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
5.15.2.1 US 95
TABLE 13 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95
5.15.2.2 Europe 97
TABLE 14 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
5.15.2.3 Rest of the world 98
TABLE 15 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98

6 VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT 99
6.1 INTRODUCTION 100
TABLE 16 VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 100
6.2 DRUGS 100
6.2.1 DRUGS MARKET, BY TYPE 100
TABLE 17 VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 101
TABLE 18 VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 101
6.2.1.1 NSAIDs 102
6.2.1.1.1 Extensive use of NSAIDS to control pain and inflammation in animals to drive market 102
TABLE 19 VETERINARY PAIN MANAGEMENT DRUGS MARKET FOR NSAIDS, BY COUNTRY, 2020–2027 (USD MILLION) 102
6.2.1.2 Opioids 103
6.2.1.2.1 Advantages of opioids such as remarkable safety profile, high efficacy, and reversibility to promote adoption 103
TABLE 20 VETERINARY PAIN MANAGEMENT DRUGS MARKET FOR OPIOIDS, BY COUNTRY, 2020–2027 (USD MILLION) 103
6.2.1.3 Local anesthetics 104
6.2.1.3.1 Ability of local anesthetics to minimize post-operative pain in animals to support demand 104
TABLE 21 VETERINARY PAIN MANAGEMENT DRUGS MARKET FOR LOCAL ANESTHETICS, BY COUNTRY, 2020–2027 (USD MILLION) 104
6.2.1.4 Alpha-2 agonists 105
6.2.1.4.1 Excessive sedation caused and loss of muscle coordination may limit use of alpha-2 agonists 105
TABLE 22 VETERINARY PAIN MANAGEMENT DRUGS MARKET FOR ALPHA-2 AGONISTS, BY COUNTRY, 2020–2027 (USD MILLION) 105
6.2.1.5 Disease-modifying osteoarthritis drugs 106
6.2.1.5.1 Ability of DMOADs to stabilize joint membranes, help with joint cartilage repair, and improve joint lubrication to increase adoption 106
TABLE 23 VETERINARY PAIN MANAGEMENT DRUGS MARKET FOR DISEASE-MODIFYING OSTEOARTHRITIS DRUGS, BY COUNTRY, 2020–2027 (USD MILLION) 106
6.2.1.6 Other drugs 107
TABLE 24 OTHER VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 107
6.2.2 DRUGS MARKET, BY ROUTE OF ADMINISTRATION 108
TABLE 25 ROUTES OF ADMINISTRATION OF MAJOR VETERINARY PAIN MANAGEMENT DRUGS 108
TABLE 26 VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 109
6.2.2.1 Oral 109
6.2.2.1.1 Affordability and ability to treat wide range of diseases to drive demand for oral drugs 109
TABLE 27 ORAL VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 110
6.2.2.2 Parenteral 110
6.2.2.2.1 Advantages such as injecting drugs at affected sites and no direct interaction with gastrointestinal tract make parenteral drugs popular 110
TABLE 28 PARENTERAL VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 111
6.2.2.3 Topical 111
6.2.2.3.1 Temporary effects of topical drugs compared with oral and parenteral drugs to hinder market growth 111
TABLE 29 TOPICAL VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 112
6.3 DEVICES 112
TABLE 30 VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 113
TABLE 31 VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 113
6.3.1 LASER THERAPY DEVICES 114
6.3.1.1 Effectiveness of laser therapy devices in curing wide range of acute and chronic pain conditions in animals to drive growth 114
TABLE 32 VETERINARY PAIN MANAGEMENT LASER THERAPY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 114
6.3.2 ELECTROMAGNETIC THERAPY DEVICES 115
6.3.2.1 Adoption of electromagnetic therapy devices to grow in coming years due to their effectiveness and ease of handling 115
TABLE 33 VETERINARY PAIN MANAGEMENT ELECTROMAGNETIC THERAPY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 115
7 VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION 116
7.1 INTRODUCTION 117
TABLE 34 VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 117
7.2 JOINT PAIN 117
TABLE 35 VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 36 VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY COUNTRY, 2020–2027 (USD MILLION) 118
7.2.1 OSTEOARTHRITIS 119
7.2.1.1 Growing prevalence of osteoarthritis in companion animals to drive market growth 119
TABLE 37 VETERINARY PAIN MANAGEMENT MARKET FOR OSTEOARTHRITIS, BY COUNTRY, 2020–2027 (USD MILLION) 120
7.2.2 MUSCULOSKELETAL DISORDERS 120
7.2.2.1 Rising number of veterinary visits to drive adoption of pain management drugs for musculoskeletal disorders 120
TABLE 38 VETERINARY PAIN MANAGEMENT MARKET FOR MUSCULOSKELETAL DISORDERS, BY COUNTRY, 2020–2027 (USD MILLION) 121
7.3 POST-OPERATIVE PAIN 121
7.3.1 INCREASING NUMBER OF ANIMALS UNDERGOING SURGERY TO DRIVE GROWTH IN THIS MARKET SEGMENT 121
TABLE 39 VETERINARY PAIN MANAGEMENT MARKET FOR POST-OPERATIVE PAIN, BY COUNTRY, 2020–2027 (USD MILLION) 122
7.4 CANCER 122
7.4.1 NEED FOR PAIN MANAGEMENT AT ALL STAGES OF CANCER TREATMENT TO SUPPORT GROWTH 122
TABLE 40 VETERINARY PAIN MANAGEMENT MARKET FOR CANCER, BY COUNTRY, 2020–2027 (USD MILLION) 123
7.5 OTHER APPLICATIONS 124
TABLE 41 VETERINARY PAIN MANAGEMENT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 124
8 VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE 125
8.1 INTRODUCTION 126
TABLE 42 VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 126
TABLE 43 VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 126
8.2 COMPANION ANIMALS 127
TABLE 44 VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 45 VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2020–2027 (USD MILLION) 128
8.2.1 DOGS 128
8.2.1.1 Higher adoption rate of dogs than other companion animals to drive market growth 128
TABLE 46 DOG POPULATION, BY COUNTRY, 2012–2020 (MILLION) 129
TABLE 47 VETERINARY PAIN MANAGEMENT MARKET FOR DOGS, BY COUNTRY, 2020–2027 (USD MILLION) 130
8.2.2 CATS 130
8.2.2.1 Growing pet cat population to support growth 130
TABLE 48 CAT POPULATION, BY COUNTRY, 2012–2020 (MILLION) 131
TABLE 49 VETERINARY PAIN MANAGEMENT MARKET FOR CATS, BY COUNTRY, 2020–2027 (USD MILLION) 131
8.2.3 HORSES 132
8.2.3.1 Growing equine health awareness to drive growth 132
TABLE 50 EQUINE POPULATION, BY COUNTRY, 2012–2019 (THOUSAND) 132
TABLE 51 VETERINARY PAIN MANAGEMENT MARKET FOR HORSES, BY COUNTRY, 2020–2027 (USD MILLION) 133
8.2.4 OTHER COMPANION ANIMALS 133
TABLE 52 VETERINARY PAIN MANAGEMENT MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2020–2027 (USD MILLION) 134
8.3 LIVESTOCK ANIMALS 134
TABLE 53 VETERINARY PAIN MANAGEMENT FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 54 VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2020–2027 (USD MILLION) 135
8.3.1 CATTLE 136
8.3.1.1 Growing consumption of meat to support market growth 136
TABLE 55 CATTLE POPULATION, BY COUNTRY, 2012–2019 (MILLION) 137
TABLE 56 VETERINARY PAIN MANAGEMENT MARKET FOR CATTLE, BY COUNTRY, 2020–2027 (USD MILLION) 137
8.3.2 SWINE 138
8.3.2.1 Growing incidence of infectious diseases to drive market growth 138
TABLE 57 SWINE POPULATION, BY COUNTRY, 2012–2019 (MILLION) 139
TABLE 58 VETERINARY PAIN MANAGEMENT MARKET FOR SWINE, BY COUNTRY, 2020–2027 (USD MILLION) 139
8.3.3 OTHER LIVESTOCK ANIMALS 140
TABLE 59 VETERINARY PAIN MANAGEMENT MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2020–2027 (USD MILLION) 140
9 VETERINARY PAIN MANAGEMENT MARKET, BY END USER 141
9.1 INTRODUCTION 142
TABLE 60 VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 142
9.2 VETERINARY HOSPITALS 142
9.2.1 GROWING INVESTMENTS IN EXPANDING VETERINARY HOSPITALS TO DRIVE MARKET GROWTH 142
TABLE 61 VETERINARY PAIN MANAGEMENT MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 143
9.3 VETERINARY CLINICS 143
9.3.1 GROWING NUMBER OF PATIENT VISITS TO PROMOTE GROWTH IN THIS MARKET SEGMENT 143
TABLE 62 VETERINARY PAIN MANAGEMENT MARKET FOR CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 144
9.4 PHARMACIES & DRUG STORES 144
9.4.1 CONVENIENCE AND EASY ACCESS TO VETERINARY DRUGS TO MAKE PHARMACIES POPULAR ALTERNATIVES 144
TABLE 63 VETERINARY PAIN MANAGEMENT MARKET FOR PHARMACIES & DRUG STORES, BY COUNTRY, 2020–2027 (USD MILLION) 145
10 VETERINARY PAIN MANAGEMENT MARKET, BY REGION 146
10.1 INTRODUCTION 147
FIGURE 39 VETERINARY PAIN MANAGEMENT MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 147
TABLE 64 VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2020–2027 (USD MILLION) 148
10.2 NORTH AMERICA 148
FIGURE 40 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET SNAPSHOT 149
TABLE 65 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 149
TABLE 66 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 150
TABLE 67 NORTH AMERICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 68 NORTH AMERICA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 150
TABLE 69 NORTH AMERICA: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 70 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 151
TABLE 71 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 72 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 152
TABLE 73 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 74 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 75 NORTH AMERICA: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 153
10.2.1 US 153
10.2.1.1 Growing pet ownership to drive market growth 153
FIGURE 41 US: POPULATION OF DOGS, 2012–2020 (MILLION) 153
TABLE 76 HEALTHCARE EXPENDITURE ON COMPANION ANIMALS, 2018 VS. 2020 154
FIGURE 42 NUMBER OF VETERINARIANS IN US, 2016–2020 154
TABLE 77 US: FOOD-PRODUCING ANIMAL POPULATION, 2001–2019 (MILLION) 154
TABLE 78 US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES, 2014–2020 155
TABLE 79 US: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 155
TABLE 80 US: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 81 US: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 156
TABLE 82 US: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 83 US: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 156
TABLE 84 US: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 85 US: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 157
TABLE 86 US: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 87 US: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS,
BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 88 US: VETERINARY PAIN MANAGEMENT MARKET, BY END USER,
2020–2027 (USD MILLION) 158
10.2.2 CANADA 158
10.2.2.1 Growing pool of skilled veterinarians to support market growth 158
FIGURE 43 CANADA: COMPANION ANIMAL POPULATION, 2016–2020 (MILLION) 159
TABLE 89 CANADA: LARGE ANIMAL POPULATION, 2001–2019 (MILLION) 159
TABLE 90 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 160
TABLE 91 CANADA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE,
2020–2027 (USD MILLION) 160
TABLE 92 CANADA: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 160
TABLE 93 CANADA: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 94 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 161
TABLE 95 CANADA: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 96 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 162
TABLE 97 CANADA: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 98 CANADA: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 99 CANADA: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 163
10.3 EUROPE 163
TABLE 100 EUROPE: COMPANION POPULATION, 2019 (MILLION) 164
TABLE 101 EUROPE: LIVESTOCK POPULATION, 2019 (MILLION) 164
TABLE 102 EUROPE: NUMBER OF VETERINARIANS, 2012–2019 165
TABLE 103 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 165
TABLE 104 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 166
TABLE 105 EUROPE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 106 EUROPE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 166
TABLE 107 EUROPE: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 167
TABLE 108 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 167
TABLE 109 EUROPE: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020–2027 (USD MILLION) 167
TABLE 110 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 168
TABLE 111 EUROPE: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 112 EUROPE: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 113 EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 169
10.3.1 GERMANY 169
10.3.1.1 Rising awareness about pet healthcare in Germany to promote market growth 169
TABLE 114 GERMANY: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 170
TABLE 115 GERMANY: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION) 170
TABLE 116 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 170
TABLE 117 GERMANY: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 118 GERMANY: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 171
TABLE 119 GERMANY: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 120 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 121 GERMANY: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 122 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 173
TABLE 123 GERMANY: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 173
TABLE 124 GERMANY: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 173
TABLE 125 GERMANY: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 174
10.3.2 FRANCE 174
10.3.2.1 Favorable government policies promoting export of livestock products to support growth 174
TABLE 126 FRANCE: PET POPULATION, 2017–2020 (MILLION) 174
TABLE 127 FRANCE: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 175
TABLE 128 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 175
TABLE 129 FRANCE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 130 FRANCE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 176
TABLE 131 FRANCE: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 177
TABLE 132 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 177
TABLE 133 FRANCE: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020–2027 (USD MILLION) 177
TABLE 134 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 178
TABLE 135 FRANCE: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 136 FRANCE: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 137 FRANCE: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 179
10.3.3 UK 179
10.3.3.1 Increasing availability of animal health insurance to aid growth 179
TABLE 138 UK: PET POPULATION, 2017–2020 (MILLION) 180
TABLE 139 UK: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 180
TABLE 140 UK: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 180
TABLE 141 UK: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 181
TABLE 142 UK: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 181
TABLE 143 UK: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 144 UK: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 182
TABLE 145 UK: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 146 UK: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 183
TABLE 147 UK: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 148 UK: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 149 UK: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 184
10.3.4 ITALY 184
10.3.4.1 Growing demand for pork to propel market growth in Italy 184
TABLE 150 ITALY: PET POPULATION, 2017–2020 (MILLION) 184
TABLE 151 ITALY: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 185
TABLE 152 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 185
TABLE 153 ITALY: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 154 ITALY: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 186
TABLE 155 ITALY: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 186
TABLE 156 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 186
TABLE 157 ITALY: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020–2027 (USD MILLION) 187
TABLE 158 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 187
TABLE 159 ITALY: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 187
TABLE 160 ITALY: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 161 ITALY: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 188
10.3.5 SPAIN 188
10.3.5.1 Rising livestock population to make Spain a relatively large market 188
TABLE 162 SPAIN: PET POPULATION, 2017–2020 (MILLION) 189
TABLE 163 SPAIN: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 189
TABLE 164 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 190
TABLE 165 SPAIN: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 190
TABLE 166 SPAIN: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 190
TABLE 167 SPAIN: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 168 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 191
TABLE 169 SPAIN: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 170 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 192
TABLE 171 SPAIN: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 172 SPAIN: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 173 SPAIN: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 193
10.3.6 REST OF EUROPE (ROE) 193
TABLE 174 REST OF EUROPE: COMPANION ANIMAL OWNERSHIP, BY COUNTRY, 2019 (MILLION) 193
TABLE 175 REST OF EUROPE: LIVESTOCK POPULATION, BY COUNTRY, 2019 (MILLION) 194
TABLE 176 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 194
TABLE 177 REST OF EUROPE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY TYPE, 2020–2027 (USD MILLION) 194
TABLE 178 REST OF EUROPE: VETERINARY PAIN MANAGEMENT DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2020–2027 (USD MILLION) 195
TABLE 179 REST OF EUROPE: VETERINARY PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 195
TABLE 180 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 195
TABLE 181 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET FOR JOINT PAIN, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 182 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 196
TABLE 183 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET FOR COMPANION ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 184 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2020–2027 (USD MILLION) 197
TABLE 185 REST OF EUROPE: VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2020–2027 (USD MILLION) 197

ページTOPに戻る

Table of Contents

Summary

The veterinary pain management market is projected to reach USD 2.5 Billion by 2027 from USD 1.8 Billion in 2022, at a CAGR of 6.7% during the forecast period. This market is subsegmented into by Product, Application, Animal, End User, And Region.

“Opioids segment holds second largest share in the veterinary pain management market by drug type in 2021”
The veterinary pain management drugs market is segment into NSAIDs, opioids, local anesthetics, alpha-2 agonists, disease-modifying osteoarthritis drugs, and other drugs on the basis of drug type. In 2021, the opioids segment accounted for a second largest share of the veterinary pain management drugs market.
“Laser therapy device segment holds largest share in the veterinary pain management market by device type in 2021 ”
Based on types of veterinary pain management devices, the market is segmented into laser therapy and electromagnetic field therapy devices. The laser therapy devices segment accounted for the largest share in 2021. Laser therapy is effective in curing a wide range of acute and chronic pain conditions; it targets and cures the cause of pain, ruling out the need for painful invasive surgeries and further use of pain relief drugs. These advantages are expected to drive the growth of laser therapy devices in the veterinary pain management devices market.
“Dog holds the largest share of Companion animal veterinary pain management market in 2021”
Based on animal type, the veterinary pain management market is segmented into companion animals and livestock animals. The companion animals segment accounted for the largest share of the veterinary pain management market in 2021. The large share of this segment can be attributed to the increasing companion animal ownership, growing awareness about animal health among pet owners, and rising pet healthcare expenditure

“China is projected to registered highest growth rate of the APAC veterinary pain management market in 2021”
The China market is estimated to grow at the highest CAGR during the forecast period. The factors such as increasing number of veterinary surgeries, increasing pet insurance, increasing the demand of animal derived factors, and increasing veterinary hospitals and clinics are contributing the growth of China market in veterinary pain management market during forecast period.

A breakdown of the primary participants (supply-side) for the veterinary pain management market referred to for this report is provided below:
• By Company Type: Tier 1–45%, Tier 2–34%, and Tier 3–21%
• By Designation: C-level–26%, Director Level–30%, and Others–44%
• By Region: North America–35%, Europe–32%, Asia Pacific–25%, Latin America- 6%, and Middle East and Africa– 2%
The prominent players in the veterinary pain management market are Boehringer Ingelheim International GmbH (Germany), Zoetis Inc. (US), Elanco Animal Health Incorporated (US), Merck & Co., Inc. (US), Dechra Pharmaceuticals (UK), Vetoquinol (France), SeQuent Scientific Limited (India), Norbrook Laboratories Limited (Ireland), Ceva Santé Animale (France), Chanelle Pharma (Ireland), and K-Laser USA (US). New product launches and acquisitions were the major strategies adopted by these payers to maintain their positions in the veterinary pain management market.
Research Coverage:
The market study covers the veterinary pain management market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, application type, animal type, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the veterinary pain management market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（cancer）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

動物用疼痛管理市場：製品（薬物（NSAIDs、Opioids）、投与経路（経口、非経口）、デバイス（レーザー））、用途（関節痛、癌）、動物（コンパニオン、家畜）、エンドユーザー（病院、薬局）別 - 2027年までの世界市場予測

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（その他）の最新刊レポート

MarketsandMarkets 社の最新刊レポート

本レポートと同じKEY WORD（cancer）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?